Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine with or without azithromycin for hospitalized or ICU patients with suspected or confirmed COVID-19
RBR-9d8z6mPhase 3Completed
- Sponsor
- HCor
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hydroxychloroquine and azithromycin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by HCor. Started Mar 2020; status: completed.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-9d8z6m.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9d8z6m.